ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009